Error: Could not add to watchlist. X

Harel 4B Selected Biomed

+ Watchlist
IL30EQY:IT
1,911.43
ILs
6.86
0.36%
As of 00:59:30 ET on 02/04/2016.
Fund Type
Open-End Fund
52Wk Range
1,902.76 - 3,250.20
1 Yr Return
-34.64%
YTD Return
-16.20%
Previous Close
1,918.29
52Wk Range
1,902.76 - 3,250.20
1 Yr Return
-34.79%
YTD Return
-16.20%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Israel
NAV (on 02/04/2016)
1,911.43
Total Assets (m ILS) (on 12/31/2015)
10.300
Inception Date
01/01/1993
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
2.51%
Expense Ratio
2.94%
Top Fund Holdings
Name Position Value % of Fund
Compugen Ltd 45.00 k 1.09 m 10.04
Mazor Robotics Ltd 47.00 k 1.01 m 9.27
Pluristem Therapeutics Inc 147.65 k 915.86 k 8.42
Evogene Ltd 30.00 k 896.70 k 8.25
Clal Biotechnology Industries 260.00 k 820.82 k 7.55
Kamada Ltd 49.72 k 773.18 k 7.11
OPKO Health Inc 20.00 k 753.20 k 6.93
Redhill Biopharma Ltd 145.00 k 662.36 k 6.09
Brainsway Ltd 24.00 k 592.56 k 5.45
iShares Nasdaq Biotechnology E 430.00 553.99 k 5.09
Profile
Harel 4B Selected Biomed is an open-end fund registered in Israel. The objective of the fund is to exceed to TA Biomed Index. The fund primarly invests in Biotechnology and Pharmaceutical equities.
ADDRESS
Ilanot Fund Management
PHONE
-
WEBSITE
-